- Language: English
- 390 Pages
- Published: December 2013
Global Deep Brain Stimulator Market 2012-2016
- Published: April 2013
- Region: Global
- 37 pages
TechNavio's analysts forecast the Global Deep Brain Stimulator market to grow at a CAGR of 16.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapidly increasing awareness about deep brain stimulation devices in the US. The Global Deep Brain Stimulator market has also been witnessing the emergence of less invasive and non-invasive treatments. However, the high cost of deep brain stimulation treatment could pose a challenge to the growth of this market.
TechNavio's report, Global Deep Brain Stimulator Market 2012-2016, has been prepared based on an in-depth market analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it covers the Global Deep Brain Stimulator market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space are Boston Scientific Corp., Medtronic Inc., and St. Jude Medical Inc.
The other vendors mentioned in the report are Advanced Neuromodulation Systems Inc., BioControl Medical Ltd., Carl Zeiss Inc., cerboMed GmbH, Codman & Shurtleff Inc., Cyberonics Inc., DePuy Inc., EndoStim Inc., EnteroMedics Inc., Neuronetics Inc., NeuroPace Inc., Neuros Medical Inc., NeuroSigma Inc., NeuroVista Corp., Nevro Corp., and The Magstim Company Ltd.
Key questions answered in this report:
- What will the market size be in 2016 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of each of these key vendors? SHOW LESS READ MORE >
01. Executive Summary
02. List of Abbreviations
04. Research Methodology
05. Scope of the Report
06. Market Landscape
06.1 Global Neuromodulation Market
Key Market Segmentation
06.2 Global Deep Brain Stimulator Market
06.3 Five Forces Analysis
07. Geographical Segmentation
08. Key Leading Countries
09. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1 Medtronic Inc.
16.2 Boston Scientific Corp.
16.3 St. Jude Medical Inc.
17. Other Reports in this Series
List of Exhibits
Exhibit 1: Global Neuromodulation Market by Category Segmentation
Exhibit 2: Global Deep Brain Stimulator Market 2012-2016 (US$ billion)
Exhibit 3: Global Deep Brain Stimulator Market by Geographical Segmentation 2012
Exhibit 4: Global Deep Brain Stimulator Market by Vendor Segmentation 2012
Exhibit 5: Business Segmentation of Medtronic Inc.
Exhibit 6: Business Segmentation of Boston Scientific Corp.
Exhibit 7: Business Segmentation of St. Jude Medical Inc.
TechNavio Announces the Publication of its Research Report - Global Deep Brain Stimulator Market 2012-2016
TechNavio recognizes the following companies as the key players in the Global Deep Brain Stimulator Market: Medtronic Inc., St. Jude Medical Inc. and Boston Scientific Corp.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''There is a general perception that DBS treatments are risky since they involve surgery to implant electrodes in the brain. Hence, less invasive and non-invasive DBS treatments are gaining greater acceptance from doctors and surgeons in the Healthcare industry. New lines of research in the R and D sector are enabling surgeons and healthcare specialists to carry out more selective stimulation. For instance, selective stimulation is used with respect to the innervation of the urinary bladder at peripheral sites (such as pudendal nerve stimulation) with the use of less invasive devices such as Bion and other implantable devices. Thus, the adoption of alternative treatments that are less invasive is seen to be an emerging trend during the forecast period.''
According to the report, one of the key drivers in this market is that DBS therapy is considered to be the standard form of care for many diseases and conditions such as epilepsy, depression, stroke, anxiety disorders, and Parkinson’s disease. Hence, this market is expected to grow at a rapid pace and achieve a similar market size to the Global Cardiac Devices market.
Further, the report states that one of the major challenges in the market is the high cost of deep brain stimulation treatments and therapies. The high cost has rendered deep brain stimulation treatments and therapies unaffordable for patients in developing nations.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Advanced Neuromodulation Systems Inc., BioControl Medical Ltd., Carl Zeiss Inc., cerboMed GmbH, Codman and Shurtleff Inc., Cyberonics Inc., DePuy Inc., EndoStim Inc., EnteroMedics Inc., Neuronetics Inc., NeuroPace Inc., Neuros Medical Inc., NeuroSigma Inc., NeuroVista Corp., Nevro Corp., and The Magstim Company Ltd.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
- Boston Scientific Corp.
- Medtronic Inc.
- St. Jude Medical Inc.
- Advanced Neuromodulation Systems Inc.
- BioControl Medical Ltd.
- Carl Zeiss Inc.
- cerboMed GmbH
- Codman & Shurtleff Inc.
- Cyberonics Inc.
- DePuy Inc.
- EndoStim Inc.
- EnteroMedics Inc.
- Neuronetics Inc.
- NeuroPace Inc.
- Neuros Medical Inc.
- NeuroSigma Inc.
- NeuroVista Corp.
- Nevro Corp.
- The Magstim Company Ltd.